EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Ligand‐Based Pharmacophore Modeling and Structure‐Based Virtual Screening for Identifying Potential Therapeutic Agents Targeting the SARS‐CoV‐2 Spike Protein‐ACE2 Receptor Interaction

Timoteo Delgado-Maldonado, Gilberto Vargas-Salas, Debasish Bandyopadhyay, Adriana Moreno-Rodríguez, Eyra Ortiz-Pérez, Gildardo Rivera iD

ChemMedChem · 2026

DOI: 10.1002/cmdc.70311 ↗

At a glance

Journal article in ChemMedChem, 2026. Written by Timoteo Delgado-Maldonado and 5 co-authors. Institution: Laboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa, México. Major MEDLINE topics: Spike Glycoprotein, Coronavirus, SARS-CoV-2, Antiviral Agents, Angiotensin-Converting Enzyme 2. 46 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Secretaría de Investigación y Posgrado, Instituto Politécnico Nacional, SIP, IPN.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Coronavirus disease (COVID‐19) remains a global health concern due to its high mortality and morbidity. In this study, we combined ligand‐based pharmacophore modeling (LBPM) with structure‐based virtual screening (SBVS) to identify novel inhibitors targeting the SARS‐CoV‐2 spike protein. Ligands from the MolPort database were screened via docking and molecular dynamics simulations at the receptor‐binding domain (RBD). Four compounds showed promising docking scores (–8.7 to –6.4 kcal/mol) and dynamic stability (root mean square deviation < 5 Å). In vitro assays confirmed that compounds C3 (IC 50 = 0.03 µM) and C4 (IC 50 = 10.4 µM) effectively inhibited spike–ACE2 binding with low cytotoxicity (CC 50 > 100 µM). These findings show the efficacy of the LBPM technique and highlight 1H‐pyrazol‐5‐ol derivatives as potential building blocks for developing new antiviral agents against SARS‐CoV‐2.

Subjects

MeSH terms (MEDLINE)

Spike Glycoprotein, CoronavirusSARS-CoV-2Antiviral AgentsAngiotensin-Converting Enzyme 2PharmacophoreHumansLigandsMolecular Docking SimulationMolecular Dynamics SimulationDrug Evaluation, PreclinicalProtein BindingStructure-Activity RelationshipBetacoronavirus

Author keywords

1H‐pyrazol‐5‐ol derivativesSARS‐CoV‐2 spike proteininhibitors viral entrypharmacophore modeling validation

Substances

Spike Glycoprotein, CoronavirusAntiviral Agentsspike protein, SARS-CoV-2Angiotensin-Converting Enzyme 2LigandsACE2 protein, human

Authors and institutions

  • Laboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa, México.
  • School of Integrative Biological and Chemical Sciences (SIBCS) & School of Earth, Environmental, and Marine Sciences (SEEMS), University of Texas Rio Grande Valley, Edinburg, Texas, USA.
  • Laboratorio de estudios Epidemiológicos, Clínicos, Diseños Experimentales e Investigación, Facultad de ciencias Químicas, Universidad Autónoma "Benito Juárez" de Oaxaca, Oaxaca, México.

ORCID profiles: Gildardo Rivera

Funding

  • Secretaría de Investigación y Posgrado, Instituto Politécnico Nacional
  • SIP, IPN

Cite

APA

Delgado-Maldonado, T., Vargas-Salas, G., Bandyopadhyay, D., Moreno-Rodríguez, A., Ortiz-Pérez, E., & Rivera, G. (2026). Ligand‐Based Pharmacophore Modeling and Structure‐Based Virtual Screening for Identifying Potential Therapeutic Agents Targeting the SARS‐CoV‐2 Spike Protein‐ACE2 Receptor Interaction. ChemMedChem. https://doi.org/10.1002/cmdc.70311

Vancouver

Delgado-Maldonado T, Vargas-Salas G, Bandyopadhyay D, Moreno-Rodríguez A, Ortiz-Pérez E, Rivera G. Ligand‐Based Pharmacophore Modeling and Structure‐Based Virtual Screening for Identifying Potential Therapeutic Agents Targeting the SARS‐CoV‐2 Spike Protein‐ACE2 Receptor Interaction. ChemMedChem. 2026. doi:10.1002/cmdc.70311

BibTeX
@article{DelgadoMaldonado2026,
  author = {Delgado-Maldonado, Timoteo and Vargas-Salas, Gilberto and Bandyopadhyay, Debasish and Moreno-Rodríguez, Adriana and Ortiz-Pérez, Eyra and Rivera, Gildardo},
  title = {Ligand‐Based Pharmacophore Modeling and Structure‐Based Virtual Screening for Identifying Potential Therapeutic Agents Targeting the SARS‐CoV‐2 Spike Protein‐ACE2 Receptor Interaction},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.70311}
}
Start for free →